Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 19/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7848126 | 0.90 | ROCK2 (0.58) | ROCK2CYP3A4ROCK1 | |
| SCHEMBL7851702 | 0.90 | ROCK2 (0.58) | ROCK2CYP3A4ROCK1 | |
| SCHEMBL7839384 | 0.88 | ROCK2 (0.53) | ROCK2CYP3A4ROCK1 | |
| SCHEMBL6719578 | 0.88 | ROCK2 (0.59) | ROCK2CYP3A4ROCK1 | |
| SCHEMBL6725372 | 0.86 | ROCK2 (0.56) | ROCK2CYP3A4ROCK1 | |
| SCHEMBL6294866 | 0.82 | NPC1 (0.70) | ROCK2CYP3A4ROCK1 | |
| SCHEMBL6725369 | 0.82 | ROCK2 (0.61) | ROCK2CYP3A4ROCK1 | |
| SCHEMBL6293834 | 0.81 | ACHE (0.62) | ROCK2CYP3A4ROCK1 | |
| SCHEMBL6295065 | 0.81 | NPC1 (0.66) | ROCK2CYP3A4ROCK1 | |
| SCHEMBL6293853 | 0.81 | ROCK2 (0.56) | ROCK2CYP3A4ROCK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010016657-A1 | Substituted isoquinoline derivatives and their use as anticonvulsants | SMITHKLINE BEECHAM P.L.C. | 2001-08-23 | — | — | US | claimed |
| US-20010016657-A1 | Substituted isoquinoline derivatives and their use as anticonvulsants | SMITHKLINE BEECHAM P.L.C. | 2001-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010016657-A1 | Substituted isoquinoline derivatives and their use as anticonvulsants | INA, GRIN2C, GRIN2A | ROCK2 2314/4885CYP3A4 168/4885ROCK1 3641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.